Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 25 results for "claris lifesciences"

Alkem Laboratories Plans For An IPO

Mumbai based generic drug maker, Alkem Laboratories is planning for an IPO to raise R1000-1500 Cr in the second half of 2015. Another report pegs the offering size to be around R3000-4000 Cr which at a 25% dilution would value the over 3 decade ... Deal Curry, 1 week ago

4 images for claris lifesciences

First Post.com, 1 month ago
Business Standard India, 2 months ago
Business Standard, 5 months ago
Moneycontrol.com, 6 months ago
First Post.com

Claris confirms patent challenge for generic Propofol in US

NEW DELHI: Claris Lifesciences today said US-based Fresenius Kabi has filed a suit against the company to block commercialisation of its abbreviated new drug application (ANDA) for Propofol, used to induce or maintain anaesthesia during surgeries. ...
 Economic Times1 month ago Claris Lifesciences confirms patent challenge in the USA  Capital Market1 month ago Fresenius Kabi files suit against Claris Lifesciences for its generic version of PROPOFOL in the USA  Equity Bulls1 month ago FRESNIUS FILES SUIT AGAINST CLARIS OVER GENERIC PROPOFOL  Pharmacy Choice1 month ago
[x]  

Board of Claris Lifesciences apporves change in financial year

At meeting held on 08 November 2014
 Business Standard2 months ago Claris Lifesciences: Outcome of board meeting  Money Control2 months ago Claris Lifesciences is a good buy: G Chokkalingam, Equinomics Research & Advisory Pvt Ltd  Economic Times2 months ago

Claris Life completes transfer of its speciality injectable biz to Claris Injectables

Claris Lifesciences Ltd has informed BSE that the Company has completed transfer of its Speciality Injectable Business by way of slump sale (as a going concern) to its wholly owned subsidiary viz. M/s. Claris Injectables Limited.
 Money Control2 months ago Claris completes transfer of speciality injectable business  Business Standard2 months ago
Business Standard

Claris Lifesciences Q3 PAT up 32% at Rs 20 cr

Ahmedabad-based Claris Lifesciences posted a 32 per cent rise in net profit for the quarter ended September 30 to Rs 20.4 crore as compared to Rs 15.5 crore in the corresponding quarter last fiscal. Net revenues for the third quarter, stood at Rs 162.1 crore ...
 Business Standard2 months ago Claris Lifesciences net profit at Rs 204 mn  India Infoline2 months ago

Claris Lifesciences consolidated net profit declines 38.29% in the September 2014 quarter

Capital Market November 11, 2014 Last Updated at 08:08 IST
 Business Standard2 months ago Claris Lifesciences standalone net profit declines 42.08% in the September 2014 quarter  Business Standard2 months ago
Business Standard India

Vibrant Gujarat 2015 sees 175 investment intentions in pharmaceuticals

Net value of the investment proposals to the tune of Rs 1,000 - 1,500 cr Sohini Das | Ahmedabad January 8, 2015 Last Updated at 15:58 IST The upcoming Vibrant Gujarat Summit has attracted nearly 175 investment intentions from local and global ...
 Business Standard India2 weeks ago

IIHMR University offers MBA Pharmaceutical Management course

IIHMR University, Jaipur is starting a two-year full time course - MBA Pharmaceutical Management. The course is designed to prepare professionals for a challenging career in pharmaceutical management in public and private sectors. The course aims ...
 PharmaBiz3 weeks ago

Torrent Pharma m-cap crosses $3 billion

AHMEDABAD: Ahmedabad based Torrent Pharmaceuticals Ltd's (TPL) market capitalization jumped to $3.028 billion (Rs 18,831.53 crore) on Monday, becoming the second pharma company from Gujarat to cross the $3 billion mark. Cadila Healthcare Ltd was ...
 Times of India1 month ago

Net sales of 50 major pharma cos up by 14%, EBDITA by 15.5% in first half of 2014-15

Despite reduction in prices of several medicines by NPPA, quality problems with US FDA, competition and slowdown in approvals, 50 top Indian pharmaceutical companies registered satisfactory growth in net sales and earnings before depreciation, ...
 PharmaBiz2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less